Skip to main content
BAX logo

Baxter International Inc.

BAXNYSEHealthcareMedical Instruments & Supplies

$25.29Today:- (-)1Y +11.57%

As of Oct 26, 2026 close

Market cap
$13.10B
P/E (TTM)
-
Forward P/E
-
Dividend yield
0.16%
52-week range
$15.73$30.00
Volume (live)
-
Avg. volume (3M)
6.65M

Baxter International (BAX) Income Statement

Baxter International reported revenue of $11.24B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 5.7% from $10.64B a year earlier. Baxter International posted a net loss of $957.00M, compared with a net loss of $649.00M a year earlier. Gross margin was 30.1% and operating margin -2.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $2.96B, up 5.3% from the same quarter a year earlier.

Baxter International Income Statement Analysis

Values in billions USD

Scroll to see more
Baxter International Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue11.2410.6410.3610.0612.1511.6711.3611.1010.58
Cost of Revenue7.876.656.215.897.287.096.606.346.11
Gross Profit3.383.984.153.554.724.594.764.764.47
Operating Expenses
Research & Development0.520.590.520.450.530.520.600.650.62
Selling, General & Administrative2.892.972.952.812.612.472.542.622.63
Operating Expenses3.693.973.446.393.372.972.993.183.19
Operating Income-0.310.010.71-2.851.351.621.771.581.29
Other Income/Expense
Interest Income0.050.070.070.020.010.020.040.050.03
Interest Expense0.290.410.51-0.41-0.160.150.110.090.09
Other Income/Expense-0.20-0.30-0.03-0.40-0.23-0.32-0.800.03-0.19
Income
Income Before Tax-0.51-0.290.24-3.251.121.290.971.621.10
Income Tax Expense0.400.040.06-0.140.080.18-0.040.070.49
Net Income-0.96-0.652.66-2.431.281.101.001.550.60
Net Income - Continuous Operations-0.96-0.650.18-2.431.281.101.001.550.60
Net Income - Discontinued Operations-0.06-0.312.480.69-----
EBITDA0.771.121.731.982.602.271.872.481.94
EBIT-0.220.120.750.911.73----
Depreciation & Amortization0.981.000.981.070.870.820.790.770.75
Earnings Per Share
Basic EPS-2.00-1.005.00-5.003.002.002.003.001.00
Diluted EPS-2.00-1.005.00-5.003.002.002.003.001.00
Basic Shares Outstanding0.510.510.510.500.500.510.510.530.54
Diluted Shares Outstanding0.510.510.510.500.510.520.520.550.56

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Baxter International Financial Statements

What was Baxter International's revenue in fiscal 2025?

Baxter International reported revenue of $11.24B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 5.7% from $10.64B a year earlier.

Is Baxter International profitable?

No. Baxter International reported a net loss of $957.00M in fiscal 2025. In fiscal 2024 it lost $649.00M.

What is Baxter International's operating margin?

Baxter International's operating income was −$308.00M on revenue of $11.24B in fiscal 2025, an operating margin of -2.7%, compared with 0.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition